Connor, Clark & Lunn Investment Management (CC&L)’s Kura Oncology KURA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,655
| Closed | -$579K | – | 1523 |
|
|
2024
Q3 | $579K | Buy |
29,655
+7,722
| +35% | +$151K | ﹤0.01% | 1059 |
|
|
2024
Q2 | $452K | Buy |
+21,933
| New | +$452K | ﹤0.01% | 1079 |
|
|
2024
Q1 | – | Sell |
-18,917
| Closed | -$272K | – | 1622 |
|
|
2023
Q4 | $272K | Buy |
+18,917
| New | +$272K | ﹤0.01% | 1195 |
|
|
2022
Q4 | – | Sell |
-53,240
| Closed | -$727K | – | 1330 |
|
|
2022
Q3 | $727K | Buy |
+53,240
| New | +$727K | ﹤0.01% | 722 |
|